The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...
Zacks.com on MSN12h
GSK's ADC Drug Gets FDA's Breakthrough Tag for Rare Bone CancerGSK plc GSK announced that the FDA has granted a Breakthrough Therapy Designation to its investigational B7-H3-targeted ...
Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indicationsNEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros Pharmac ...
With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback